Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Brilacidin by Alfasigma for Proctitis: Likelihood of Approval
Brilacidin is under clinical development by Alfasigma and currently in Phase II for Proctitis. According to GlobalData, Phase II drugs...
Data Insights
Brilacidin by Innovation Pharmaceuticals for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Brilacidin is under clinical development by Innovation Pharmaceuticals and currently in Phase II for Coronavirus Disease 2019 (COVID-19). According to...